BARCLAYS PLC - STRONGBRIDGE BIOPHARMA PLC ownership

STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 71 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of STRONGBRIDGE BIOPHARMA PLC
ValueSharesWeighting
Q3 2021$14,000
-90.5%
6,969
-86.0%
0.00%
Q2 2021$148,000
+45.1%
49,839
+35.4%
0.00%
Q1 2021$102,000
+200.0%
36,807
+159.0%
0.00%
Q4 2020$34,000
-2.9%
14,212
-13.8%
0.00%
Q3 2020$35,000
-52.7%
16,478
-16.8%
0.00%
Q2 2020$74,000
+221.7%
19,797
+65.0%
0.00%
Q1 2020$23,000
-70.1%
12,001
-67.6%
0.00%
Q4 2019$77,000
+67.4%
37,077
+91.5%
0.00%
Q3 2019$46,000
-57.4%
19,359
-43.9%
0.00%
Q2 2019$108,000
-10.0%
34,519
+43.2%
0.00%
Q1 2019$120,000
+11900.0%
24,106
+11601.9%
0.00%
Q4 2018$1,000
-99.7%
206
-99.7%
0.00%
Q3 2018$350,000
+4.5%
72,240
+29.5%
0.00%
Q2 2018$335,000
+78.2%
55,771
+164.2%
0.00%
Q1 2018$188,000
+571.4%
21,109
+429.8%
0.00%
Q4 2017$28,000
+600.0%
3,984
+640.5%
0.00%
Q3 2017$4,000538
+3064.7%
0.00%
Q2 2017$0
-100.0%
17
-99.9%
0.00%
Q1 2017$73,00015,3140.00%
Other shareholders
STRONGBRIDGE BIOPHARMA PLC shareholders Q2 2020
NameSharesValueWeighting ↓
CAXTON CORP 6,604,065$29,586,00035.89%
Opaleye Management Inc. 1,390,000$6,227,0002.32%
Prosight Management, LP 937,900$4,202,0002.17%
Broadfin Capital, LLC 2,821,722$12,641,0001.66%
22NW, LP 404,410$1,812,0001.13%
ARMISTICE CAPITAL, LLC 2,878,000$12,893,0000.98%
NEA Management Company, LLC 4,141,308$18,553,0000.74%
Harvest Capital Strategies LLC 543,652$2,436,0000.68%
SPHERA FUNDS MANAGEMENT LTD. 931,600$4,174,0000.47%
ESSEX INVESTMENT MANAGEMENT CO LLC 988,750$4,430,0000.35%
View complete list of STRONGBRIDGE BIOPHARMA PLC shareholders